| 2.16.840.1.113883.6.257 |
mds | 0 | 0 |
Minimum Data Set for Long Term Care |
| 2.16.840.1.113883.6.258 |
caefi-rcco | 0 | 0 |
Canadian Adverse Event Following Immunization reporting criteria and concurrent observations |
| 2.16.840.1.113883.6.259 |
hsloc, HSLOC | 0 | 0 |
Healthcare Service Location |
| 2.16.840.1.113883.6.260 |
260, ICD-10DualCoding, ICD10DualCoding, icd-10-dualCoding | 0 | 0 |
ICD-10 Dual Code Expression |
| 2.16.840.1.113883.6.261 |
ICD-9DualCoding, ICD9DualCoding | 0 | 0 |
|
| 2.16.840.1.113883.6.262 |
nHSNSpinalFusionApproach, NHSNSpinalFusionApproach | 0 | 0 |
NHSN Spinal Fusion Approach |
| 2.16.840.1.113883.6.263 |
nHSNHipReplacement, NHSNHipReplacement | 0 | 0 |
NHSN Hip Replacement |
| 2.16.840.1.113883.6.264 |
nHSNKneeReplacement, NHSNKneeReplacement | 0 | 0 |
NHSN KneeR eplacement |
| 2.16.840.1.113883.6.265 |
nHSNSSILocationType, NHSNSSILocationType | 0 | 0 |
NHSN SSI Location Type |
| 2.16.840.1.113883.6.266 |
nHSNBSIRiskFactors, NHSNBSIRiskFactors | 0 | 0 |
NHSN BSI Risk Factors |
| 2.16.840.1.113883.6.267 |
nHSNLCBIPathways, NHSNLCBIPathways | 0 | 0 |
NHSN LCBI Pathways |
| 2.16.840.1.113883.6.268 |
nHSNInfectionType, NHSNInfectionType | 0 | 0 |
NHSN Infection Type |
| 2.16.840.1.113883.6.269 |
nHSNSpinalFusionLevel, NHSNSpinalFusionLevel | 0 | 0 |
NHSN Spinal Fusion Level |
| 2.16.840.1.113883.6.270 |
nHSNSummaryData, NHSNSummaryData | 0 | 0 |
NHSN Summary Data |
| 2.16.840.1.113883.6.271 |
nHSNProcedureCategory, NHSNProcedureCategory | 0 | 0 |
NHSN Procedure Category |
| 2.16.840.1.113883.6.272 |
nHSNSSIAnatomicSite, NHSNSSIAnatomicSite | 0 | 0 |
NHSN SSI Anatomic Site |
| 2.16.840.1.113883.6.273 |
nHSNOccasionOfDetection, NHSNOccasionOfDetection | 0 | 0 |
NHSN Occasion Of Detection |
| 2.16.840.1.113883.6.274 |
nHSNVocabulary, NHSNVocabulary | 0 | 0 |
NHSN HAI Vocabulary |
| 2.16.840.1.113883.6.275 |
usEPAsrs, UsEPAsrs | 1 | 1 |
US EPA Substance Registry System |
| 2.16.840.1.113883.6.276 |
gMDN, GMDN | 0 | 0 |
Global Medical Device Nomenclature |
| 2.16.840.1.113883.6.277 |
cdcNHSN, CDCNHSN | 0 | 0 |
CDC - National Healthcare Safety Network (NHSN) code system |
| 2.16.840.1.113883.6.278 |
epsg-crs, EpsgCrs | 0 | 0 |
European Petroleum Survey Group Geodetic Parameter Dataset Coordinate Reference System |
| 2.16.840.1.113883.6.279 |
epsg-ca, EpsgCa | 0 | 0 |
European Petroleum Survey Group Geodetic Parameter Dataset Coordinate Axis |
| 2.16.840.1.113883.6.280 |
refSeq, RefSeq, v3-refSeq | 0 | 0 |
The Reference Sequence (RefSeq) is one of the NCBI projects, the RefSeq collection aims to provide a comprehensive, integrated,… |
| 2.16.840.1.113883.6.281 |
hgnc, HGNCGenes, v3-hgnc | 0 | 0 |
HUGO Gene Nomenclature |
| 2.16.840.1.113883.6.282 |
hgvs, Hgvs, v3-hgvs | 0 | 0 |
HGVS nomenclatures are the guidelines for mutation nomenclature made by the Human Genome Variation Society |
| 2.16.840.1.113883.6.283 |
lrg, Lrg, v3-lrg | 0 | 0 |
Locus Reference Genomic Sequences (LRG) |
| 2.16.840.1.113883.6.284 |
dbSNP, DbSNP, v3-dbSNP | 0 | 0 |
In collaboration with the National Human Genome Research Institute, The National Center for Biotechnology Information has estab… |
| 2.16.840.1.113883.6.285 |
hcpcs-Level-II, HCPCSLevelII | 0 | 0 |
HCPCS Level II Alphanumeric Codes |
| 2.16.840.1.113883.6.286 |
fdbHIC3 | 0 | 0 |
First DataBank Hierarchical Specific Therapeutic Class Code |
| 2.16.840.1.113883.6.287 |
rxTerms | 0 | 0 |
RxTerms |
| 2.16.840.1.113883.6.288 |
fdbHICL-SEQNO | 0 | 0 |
First DataBank Ingredient List Identifier |
| 2.16.840.1.113883.6.289 |
fdbHIC4 | 0 | 0 |
Hierarchical Base Ingredient Code |
| 2.16.840.1.113883.6.290 |
abcCodabar | 0 | 0 |
ABC Codabar |
| 2.16.840.1.113883.6.291 |
cLIAInVitroDiagnosticsDatabase | 0 | 0 |
Clinical Laboratory Improvement Amendments (CLIA) InVitro Diagnostics Database |
| 2.16.840.1.113883.6.292 |
whoDDType | 0 | 0 |
WHO Drug Dictionary Type |
| 2.16.840.1.113883.6.293 |
whoDDEdition | 0 | 0 |
WHO Drug Dictionary Edition |
| 2.16.840.1.113883.6.294 |
whoDDMedProdId | 0 | 0 |
WHO Drug Dictionary Medicinal Product ID |
| 2.16.840.1.113883.6.295 |
whoDDPharmForm | 0 | 0 |
WHO Drug Dictionary Pharmaceutical Form |
| 2.16.840.1.113883.6.296 |
whoDDReference | 0 | 0 |
WHO Drug Dictionary Validation Reference |
| 2.16.840.1.113883.6.297 |
whoDDSDG | 0 | 0 |
WHO Drug Dictionary Standard Drug Grouping |
| 2.16.840.1.113883.6.298 |
whoDDSDGScope | 0 | 0 |
WHO Drug Dictionary Standard Drug Grouping Scope |
| 2.16.840.1.113883.6.299 |
iscn, ISCN | 0 | 0 |
The International System for Human Cytogenetic Nomenclature |
| 2.16.840.1.113883.6.300 |
naic-CoCode-cs, NAICCompanyCodes, NAIC_Company_Codes | 0 | 0 |
NAIC Company Code-code set |
| 2.16.840.1.113883.6.301 |
nubc-UB-04-Manual-cs | 11 | 11 |
nubc-UB-04-Manual-code set |
| 2.16.840.1.113883.6.302 |
un-sp-sc | 0 | 0 |
United Nations Standard Products and Services Code |
| 2.16.840.1.113883.6.303 |
fdaProductClassificationSystem | 0 | 0 |
FDA Product Classification System |
| 2.16.840.1.113883.6.304 |
vis-doc-type | 0 | 0 |
Vaccine Information Sheet document type |
| 2.16.840.1.113883.6.305 |
fhir-special-values | 0 | 0 |
Fast Healthcare Interoperability Resources (FHIR) Special Values |
| 2.16.840.1.113883.6.306 |
fhir-resource-types | 0 | 0 |
Fast Healthcare Interoperability Resources (FHIR) Resource Types |